# UNIVERSITY OF MINNESOTA: Interactions between drug combinations and resistance acquisition risk for antimalarial ATP4 inhibitors

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF MINNESOTA |
| Location | MINNEAPOLIS, MN |
| Project | Interactions between drug combinations and resistance acquisition risk for antimalarial ATP4 inhibitors |
| Project number | 7R01AI184710-03 |
| Mechanism | R01 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $688,164 |
| Awarded | 2026-09-18 |
| Project period | 2025-11-25 to 2029-05-31 |
| UEI | KABJZBBJ4B54 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11457287). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.